s Terms of Use | I2P: Information to Pharmacists - Archive
Publication Date 01/07/2014         Volume. 6 No. 6   
Information to Pharmacists

Editorial

From the desk of the editor

Welcome to the July 2014 homepage edition of i2P (Information to Pharmacists) E-Magazine.
At the commencement of 2014 i2P focused on the need for the entire profession of pharmacy and its associated industry supports to undergo a renewal and regeneration.
We are now half-way through this year and it is quite apparent that pharmacy leaders do not yet have a cohesive and clear sense of direction.
Maybe the new initiative by Woolworths to deliver clinical service through young pharmacists and nurses may sharpen their focus.
If not, community pharmacy can look forward to losing a substantial and profitable market share of the clinical services market.
Who would you blame when that happens?
But I have to admit there is some effort, even though the results are but meagre.
In this edition of i2P we focus on the need for research about community pharmacy, the lack of activity from practicing pharmacists and when some research is delivered, a disconnect appears in its interpretation and implementation.

read more
open full screen

Recent Comments

Click here to read...

News Flash

Newsflash Updates for July 2014

Newsflash Updates

Regular weekly updates that supplement the regular monthly homepage edition of i2P. 
Access and click on the title links that are illustrated

Comments: 1

read more
open full screen

Feature Contribution

Woolworths Pharmacy - Getting One Stage Closer

Neil Johnston

It started with “tablet” computers deployed on shelves inside the retailer Coles, specifically to provide information to consumers relating to pain management and the sale of strong analgesics.
This development was reported in i2P under the title Coles Pharmacy Expansion and the Arid PGA Landscape”
In that article we reported that qualified information was a missing link that had come out of Coles market research as the reason to why it had not succeeded in dominating the pain market.
Of course, Woolworths was working on the same problem at the same time and had come up with a better solution - real people with good information.

Comments: 5

read more
open full screen

Intensive Exposition without crossing over with a supermarket

Fiona Sartoretto Verna AIAPP

Editor's Note: The understanding of a pharmacy's presentation through the research that goes into the design of fixtures and fittings that highlight displays, is a never-ending component of pharmacy marketing.
Over the past decade, Australian pharmacy shop presentations have fallen behind in standards of excellence.
It does not take rocket science - you just have to open your eyes.
Recently, our two major supermarkets, Woolworths and Coles, have entered into the field of drug and condition information provision - right into the heartland of Australian Pharmacy.

read more
open full screen

The sure way to drive business away

Gerald Quigley

I attended the Pregnancy, Baby and Children’s Expo in Brisbane recently.
What an eye and ear opening event that was!
Young Mums, mature Mums, partners of all ages, grandparents and friends……...many asking about health issues and seeking reassurances that they were doing the right thing.

Comments: 1

read more
open full screen

‘Marketing Based Medicine’ – how bad is it?

Baz Bardoe

It should be the scandal of the century.
It potentially affects the health of almost everyone.
Healthcare providers and consumers alike should be up in arms. But apart from coverage in a few credible news sources the problem of ‘Marketing Based Medicine,’ as psychiatrist Dr Peter Parry terms it, hasn’t as yet generated the kind of universal outrage one might expect.

read more
open full screen

Community Pharmacy Research - Are You Involved?

Mark Coleman

Government funding is always scarce and restricted.
If you are ever going to be a recipient of government funds you will need to fortify any application with evidence.
From a government perspective, this minimises risk.
I must admit that while I see evidence of research projects being managed by the PGA, I rarely see community pharmacists individually and actively engaged in the type of research that would further their own aims and objectives (and survival).

read more
open full screen

Organisational Amnesia and the Lack of a Curator Inhibits Cultural Progress

Neil Johnston

Most of us leave a tremendous impact on pharmacies we work for (as proprietors, managers, contractors or employees)—in ways we’re not even aware of.
But organisational memories are often all too short, and without a central way to record that impact and capture the knowledge and individual contributions, they become lost to time.
It is ironic that technology has provided us with phenomenal tools for communication and connection, but much of it has also sped up our work lives and made knowledge and memory at work much more ephemeral.

read more
open full screen

Academics on the payroll: the advertising you don't see

Staff Writer

This article was first published in The Conversation and was written by Wendy Lipworth, University of Sydney and Ian Kerridge, University of Sydney
In the endless drive to get people’s attention, advertising is going ‘native’, creeping in to places formerly reserved for editorial content. In this Native Advertising series we find out what it looks like, if readers can tell the difference, and more importantly, whether they care.
i2P has republished the article as it supports our own independent and ongoing investigations on how drug companies are involved in marketing-based medicine rather than evidence-based medicine.

read more
open full screen

I’ve been thinking about admitting wrong.

Mark Neuenschwander

Editor's Note: This is an early article by Mark Neuenschwander we have republished after the soul-searching surrounding a recent Australian dispensing error involving methotrexate.
Hmm. There’s more than one way you could take that, huh? Like Someday when I get around to it (I’m not sure) I may admit that I was wrong about something. Actually, I’ve been thinking about the concept of admitting wrong. So don’t get your hopes up. No juicy confessions this month except that I wish it were easier for me to admit when I have been wrong or made a mistake.
Brian Goldman, an ER physician from Toronto, is host of the award-winning White Coat, Black Art on CBC Radio and slated to deliver the keynote at The unSUMMIT for Bedside Barcoding in Anaheim this May. His TED lecture, entitled, “Doctors make mistakes. Can we talk about it?” had already been viewed by 386,072 others before I watched it last week.

read more
open full screen

Dispensing errors – a ripple effect of damage

Kay Dunkley - BPharm, Grad Dip Hosp Pharm, Grad Dip Health Admin, MPS, MSHPA

Most readers will be aware of recent publicity relating to dispensing errors and in particular to deaths caused by methotrexate being incorrectly packed in dose administration aids.
The Pharmacy Board of Australia (PBA), in its Communique of 13 June 2014, described a methotrexate packing error leading to the death of a patient and noted “extra vigilance is required to be exercised by pharmacists with these drugs”.
This same case was reported by A Current Affair (ACA) in its program on Friday 20 June
http://aca.ninemsn.com.au/article/8863098/prescription-drug-warning

read more
open full screen

Take a vacation from your vocation

Harvey Mackay

Have you ever had one of those days when all you could think was, “Gosh, do I need a vacation.”
Of course you have – because all work and no play aren’t good for anyone.
A vacation doesn’t have to be two weeks on a tropical island, or even a long weekend at the beach. 
A vacation just means taking a break from your everyday activities. 
A change of pace. 
It doesn’t matter where.
Everyone needs a vacation to rejuvenate mentally and physically. 
But did you also know that you can help boost our economy by taking some days off? 
Call it your personal stimulus package.

read more
open full screen

Explainer: what is peer review?

Staff Writer

This article was first published in the Conversation. It caught our eye because "peer review" it is one of the standards for evidence-based medicines that has also been corrupted by global pharma.
The article is republished by i2P as part of its ongoing investigation into scientific fraud and was writtenby Andre Spicer, City University London and Thomas Roulet, University of Oxford
We’ve all heard the phrase “peer review” as giving credence to research and scholarly papers, but what does it actually mean?
How does it work?
Peer review is one of the gold standards of science. It’s a process where scientists (“peers”) evaluate the quality of other scientists' work. By doing this, they aim to ensure the work is rigorous, coherent, uses past research and adds to what we already knew.
Most scientific journals, conferences and grant applications have some sort of peer review system. In most cases it is “double blind” peer review. This means evaluators do not know the author(s), and the author(s) do not know the identity of the evaluators.
The intention behind this system is to ensure evaluation is not biased.
The more prestigious the journal, conference, or grant, the more demanding will be the review process, and the more likely the rejection. This prestige is why these papers tend to be more read and more cited.

read more
open full screen

Dentists from the dark side?

Loretta Marron OAM BSc

While dining out with an elderly friend, I noticed that he kept his false tooth plate in his shirt pocket. He had recently had seven amalgam-filled teeth removed, because he believed that their toxins were making him sick; but his new plate was uncomfortable. He had been treated by an 'holistic dentist'. Claiming to offer a "safe and healthier alternative" to conventional dentistry, are they committed to our overall health and wellbeing or are they promoting unjustified fear, unnecessarily extracting teeth and wasting our money?

read more
open full screen

Planning for Profit in 2015 – Your key to Business Success

Chris Foster

We are now entering a new financial year and it’s a great time to reflect on last year and highlight those things that went well and those that may have impacted negatively in the pursuit of your goals.
It's also a great to spend some time re-evaluating your personal and business short, medium and long term goals in the light of events over the last year.
The achievement of your goals will in many cases be dependent on setting and aspiring to specific financial targets. It's important that recognise that many of your personal goals will require you to generate sufficient business profits to fund those aspirations

read more
open full screen

ReWalk™ Personal Exoskeleton System Cleared by FDA for Home Use

Staff Writer

Exoskeleton leader ReWalk Robotics announced today that the U.S. Food and Drug Administration has cleared the company’s ReWalk Personal System for use at home and in the community.
ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk.
ReWalk, the only exoskeleton with FDA clearance via clinical studies and extensive performance testing for personal use, is now available throughout the United States.

read more
open full screen

Attracting and Retaining Great People

Barry Urquhart

Welcome to the new financial year in Australia.
For many in business the past year has been described as a challenging period.
Adjectives are a key feature of the English language.  In the business lexicon their use can be, and often is evocative and stimulate creative images.  But they can also contribute to inexact, emotional perceptions.
Throughout the financial pages of newspapers and business magazines adjectives abound.
References to “hot” money draw attention and comment.  The recent wave of funds from Chinese investors, keen to remove their wealth from the jurisdiction and control of government regulations is creating a potential property bubble in Australia.

read more
open full screen

Updating Your Values - Extending Your Culture

Neil Johnston

Pharmacy culture is dormant.
Being comprised of values, unless each value is continually addressed, updated or deleted, entire organisations can stagnate (or entire professions such as the pharmacy profession).
Good values offer a strong sense of security, knowing that if you operate within the boundaries of your values, you will succeed in your endeavours.

read more
open full screen

Evidence-based medicine is broken. Why we need data and technology to fix it

Staff Writer

The following article is reprinted from The Conversation and forms up part of our library collection on evidence-based medicines.
At i2P we also believe that the current model of evidence is so fractured it will never be able to be repaired.
All that can happen is that health professionals should independently test and verify through their own investigations what evidence exists to prescribe a medicine of any potency.
Health professionals that have patients (such as pharmacists) are ideally placed to observe and record the efficacy for medicines.
All else should confine their criticisms to their evidence of the actual evidence published.
If there are holes in it then share that evidence with the rest of the world.
Otherwise, do not be in such a hurry to criticise professions that have good experience and judgement to make a good choice on behalf of their patients, simply because good evidence has not caught up with reality.

read more
open full screen

Laropiprant is the Bad One; Niacin is/was/will always be the Good One

Staff Writer

Orthomolecular Medicine News Service, July 25, 2014
Laropiprant is the Bad One; Niacin is/was/will always be the Good One
by W. Todd Penberthy, PhD

(OMNS July 25, 2014) Niacin has been used for over 60 years in tens of thousands of patients with tremendously favorable therapeutic benefit (Carlson 2005).
In the first-person NY Times best seller, "8 Weeks to a Cure for Cholesterol," the author describes his journey from being a walking heart attack time bomb to a becoming a healthy individual.
He hails high-dose niacin as the one treatment that did more to correct his poor lipid profile than any other (Kowalski 2001).

read more
open full screen

Culture Drive & Pharmacy Renewal

Neil Johnston

Deep within all of us we have a core set of values and beliefs that create the standards of behaviour that we align with when we set a particular direction in life.
Directions may change many times over a lifetime, but with life experiences and maturity values may increase in number or gain greater depth.
All of this is embraced under one word – “culture”.
When a business is born it will only develop if it has a sound culture, and the values that comprise that culture are initially inherent in the business founder.
A sound business culture equates to a successful business and that success is often expressed in the term “goodwill” which can be eventually translated to a dollar value.

read more
open full screen

ReWalk™ Personal Exoskeleton System Cleared by FDA for Home Use

Staff Writer

Exoskeleton leader ReWalk Robotics announced today that the U.S. Food and Drug Administration has cleared the company’s ReWalk Personal System for use at home and in the community.
ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk.
ReWalk, the only exoskeleton with FDA clearance via clinical studies and extensive performance testing for personal use, is now available throughout the United States.

read more
open full screen

Pharmacy 2014 - Pharmacy Management Conference

Neil Johnston

The brave new world of health and wellness is not the enemy of Pharmacy, it is its champion.
Australian futurist, Morris Miselowski, one of the world's leading business visionaries, will present the Opening Keynote address on Pharmacy's Future in the new Health and Wellness Landscape at 2.00pm on Wednesday July 30.
Morris believes the key to better health care could already be in your pocket, with doctors soon set to prescribe iPhone apps, instead of pills.
Technology will revolutionise the health industry - a paradigm shift from healthcare to personal wellness.
Health and wellness applications on smartphones are already big news, and are dramatically changing the way we manage our personal health and everyday wellness.

read more
open full screen

Generation and Application of Community Pharmacy Research

Neil Johnston

Editor’s Note: We have had a number of articles in this issue relating to pharmacy research.
The PGA has conducted a number of research initiatives over the years, including one recently reported in Pharmacy News that resulted from an analysis of the QCPP Patient Questionnaire.
Pharmacy Guild president, George Tambassis, appears to have authored the article following, and there also appears to be a disconnect between the survey report and its target audience illustrated by one of the respondent comments published.
I have asked Mark Coleman to follow through, elaborate and comment:

read more
open full screen

Terms of Use

Conditions of Use

The websites that form the network of Computachem Services Media sites (hereinafter referred to individually as a "CCM Site" or collectively the "CCM Sites") are owned and operated by N & G Johnston Pty Ltd. The CCM Sites include information and data provided by Computachem Services and a number of third parties ("Content Providers"), and are marketed under various trade marks including i2P E-Magazine and Hooked on Health Solutions.
These terms of use, together with the Subscription Terms and any other additional terms, conditions, notices and disclaimers contained elsewhere on the CCM Sites, form the terms and conditions of supply of material on, use of and access to the CCM Sites. If you use any of the CCM Sites, you agree to be bound by these terms. Computachem Services reserves the right to change these terms by posting changes online. It is your responsibility to check the terms regularly. Your continued use of the CCM Sites after any changes are made to these terms constitutes an acknowledgement and agreement by you that you accept and agree to be bound by the terms and any changes made to them. Should you object to any of these conditions or any subsequent modifications your only recourse is to immediately discontinue your use of the CCM Sites.

Accuracy of information

All material on the CCM Sites is provided in good faith and is derived from sources believed to be accurate and current as at the date of publication. Your use of the CCM Sites is at your own sole risk. Access to the CCM Sites is provided on an "as available" basis. Unless expressly stated otherwise, neither Computachem Services nor its related bodies corporate, its or their directors or employees or any Content Provider (collectively, the "Protected Parties") makes any representation or warranty that any material on any of the CCM Sites will be reliable, accurate or complete or that your access to any of the CCM Sites will be uninterrupted, timely or secure. Neither Computachem Services nor any of the Protected Parties will be liable for any damage or loss resulting from any errors in or omissions from the material on the CCM Sites, nor any action or decision by you in reliance on the material on the CCM Sites, nor any interruption, delay in operation or transmission, virus, communications failure, internet access difficulties, or malfunction in equipment or software. Computachem Services reserves the right at any time without prior notice to change or discontinue any feature of the CCM Sites and to change the presentation or substance of the material on the CCM Sites if required to do so by reasons outside its control or if the material is changed or ceases to be provided for any reason by a Content Provider.

General information - non advisory

The material on the CCM Sites provides general information only. It is not intended as advice and must not be relied upon as such. The material has not been prepared by taking into account the business objectives, financial situation or needs of any individual pharmacists. You should make your own inquiries and if necessary take independent advice tailored to your specific circumstances before making any decisions.

Copyright and intellectual property

The material on the CCM Sites is copyright protected and in some cases is published by Computachem Services under licence. Except for the temporary copy held in the computer's cache and a single permanent copy for your personal reference, the material may not otherwise be used, copied, reproduced, published, distributed, sold or resold, stored in a retrieval system, altered or transmitted in any form or by any means in whole or part or otherwise disseminated to others (except where such use constitutes fair dealing under the Copyright Act 1968) without the prior written approval of Computachem Services or the appropriate Content Provider or other supplier or licensor of Computachem Services. I2P, i2p.com.au, the i2P logo and the mastheads on i2p.com.au and the other CCM Sites are trademarks or registered trademarks of Computachem Services and its related bodies corporate. Other trademarks and logos may be displayed on i2p.com.au and the other CCM Sites from time to time. These may belong to a Content Provider or other third party. Nothing displayed on i2P.com.au or the CCM Sites should be construed as granting any licence or right of use of any logo, masthead or trademark displayed, without the express written permission of the relevant owner.

Third party links and advertising

Hyperlinks and pointers to websites operated by third parties will appear on the CCM Sites from time to time. These websites do not form part of the CCM Sites and are not under the control of Computachem Services or its related bodies corporate and neither Computachem Services nor its related bodies corporate have any responsibility for the content of any such hyperlink or linked website. If you link to any such websites, you leave the CCM Sites and do so entirely at your own risk. The CCM Sites displays third party advertisements, which may or may not contain hyperlinks or referral buttons to websites operated by third parties. The display of such advertising does not in any way imply a recommendation or endorsement by Computachem Services or its related bodies corporate of the relevant advertiser, its products or services or any such linked website. If you contact a third party using functionality provided on the CCM Sites, including via e-mail, Computachem Services accepts no responsibility for any actions taken by that third party in response to your communication or for any transactions entered into between you and the relevant third party.

Your use of the CCM Sites

Without limiting any other provision of these terms and conditions, you may not use or permit the use of any part of the material on the CCM Sites:

  • to establish, maintain or provide, or assist in establishing, maintaining or providing your own publications, internet site or other means of distribution; or other than for your own personal use or in the ordinary course of your own business; or for any illegal purpose.

You agree to abide by all applicable laws and regulations in accessing and using the CCM Sites and the material on it. If Computachem Services determines or suspects that you have breached these terms (including, but not limited to, by sharing your username and password in breach of the Subscription Terms), or if it is required to do so by a Content Provider because of a suspected breach by you of these terms, Computachem Services may immediately suspend or terminate your access to any of the CCM Sites. You agree to indemnify Computachem Services and the Protected Parties against any losses, liabilities, damages, costs or expenses suffered or incurred by them in connection with any breach of these terms and conditions or any other legal obligation by you or your use of or conduct on the CCM Sites. Computachem Services has no obligation to you to monitor your use of the CCM Sites. However, Computachem Services retains the right at all times to monitor, retain and disclose any information relating to your use of the CCM Sites as necessary to satisfy any applicable law, regulation, legal process, governmental request or legal obligation. In addition, if Computachem Services reasonably suspects any misuse of any CCM Site or information or content supplied by way of any CCM Site, Computachem Services may, on giving you at least 10 days notice in writing, audit all records, systems, attachments, apparatus, books and records or other such material to verify your compliance with this Agreement. Any audit will be conducted during normal business hours and subject to your reasonable security and confidentiality requirements. If any audit by Computachem Services discloses any breach of this Agreement, you will pay, within 30 days of us notifying you, any underpayment and our reasonable audit costs or any reasonable estimate of any discrepancy discovered pursuant to such audit arising from your misuse of any CCM Site product or service.

Disclosure of benefits

Reports and newsletters offered for sale or subscription by a Content Provider may from time to time be referred to or advertised on the CCM Sites. Computachem Services or its related bodies corporate may receive a referral commission based on sales or subscriptions of such reports and newsletters taken up by users of the CCM Sites Computachem Services has entered into agreements with Content Providers under which it pays a fee for the information and data provided by the Content Providers. Except as outlined above, Computachem Services does not receive any commissions or other benefits from Content Providers based on the material you access or use on the CCM Sites.

Limitation of liability

Computachem Services and its related bodies corporate do not exclude any rights or remedies available to you under the Trade Practices Act 1974 or any similar State or Territory legislation that cannot be excluded, restricted or modified. Otherwise, all conditions and warranties in respect of the CCM Sites and the material on it that may be implied by law are excluded. To the extent Computachem Services supplies goods or services which are not of a kind ordinarily acquired for personal, domestic or household use or consumption, its liability for breach of any implied warranty or condition which cannot be excluded is restricted, at Computachem Services's option, to:

  1. in the case of services supplied or offered by Computachem Services, the re-supply of those services or the payment of the cost of having those services re-supplied; and

  2. in the case of goods supplied or offered by Computachem Services, the replacement of the goods or the supply of equivalent goods, the repair of the goods, the payment of the cost of replacing the goods or the payment of the cost of having the goods repaired.

Subject to the above qualifications, you expressly agree that in no circumstances will Computachem Services or the Protected Parties be liable to you for any damage or loss (including, but not limited to, any indirect or consequential loss or any loss of profits or revenues whatsoever) however caused (including, but not limited to, by the negligence of Computachem Services or a Protected Party) suffered or incurred by you in connection with your use of the CCM Sites.

General

In entering into this agreement with you and obtaining the benefit of any exclusion of liability, disclaimer or indemnity, Computachem Services acts on its own behalf and as trustee for each of the Protected Parties. Where specific provisions of these terms and conditions relate to a particular Content Provider, they are not intended to limit or otherwise affect the application of other general provisions to Computachem Services or other Content Providers. These terms and all other additional terms which govern your use and access to the CCM Sites will be governed by and construed in accordance with the laws of New South Wales, Australia.

Publication Guidelines

The websites that form the network of Computachem Services Media sites (hereinafter referred to from now individually as a "CCM Site" or collectively the "CCM Sites") are owned and operated by N & G Johnston Pty Limited ( or "us"/"our"/"we").

If you provide us with content for use on the CCM Sites and/or hard copy publications at our invitation, or if you have comments, photographs, video footage of newsworthy people or events or other content (referred to from now on as "your content") you wish to send us in relation to articles or multimedia material posted on the CCM Sites and which may be posted on the CCM Site by Computachem Services, we can only accept your content if you comply with the terms and conditions set out below.

Terms and Conditions for the Supply of Your Content

  1. If you send comments or content to Computachem Services, you agree to be bound by these terms and conditions.
  2. These terms and conditions are subject to change at our sole discretion.
  3. You must not provide your content to Computachem Services if you are under 18 years of age.
  4. Computachem Services will determine, at its discretion and at any time, whether to publish (or remove from a CCM Site) any of your content.
  5. Computachem Services may edit your content at its sole discretion prior to posting it on the CCM Site.
  6. You acknowledge that Computachem Services may use all intellectual property rights in your content throughout the world, in perpetuity, without restriction and without making payment to you, including publication of that material in hard copy publications or in electronic media, using your content in advertising and promotional material for Computachem Services and permitting others to do any of these, including when Computachem Services and others receive payment for this.
  7. You waive all moral rights in your content and consent to anything which Computachem Services (or any person permitted to do so by Computachem Services) may do in relation to your content which would otherwise be in breach of your moral rights. Accordingly, you agree that Computachem Services may use your content without attributing you as the source of, or otherwise in relation to your content.
  8. You warrant that: (a) you own your content and all rights in relation to your content prior to providing it to Computachem Services for posting on our CCM Sites; (b) you obtained your content in a manner which does not breach any laws or the rights of any person; (c) your content is accurate, depicts real people and events, is not digitally altered or fabricated in any way any does not involved the impersonation of any person or entity or falsely state or otherwise misrepresent any affiliation with a person or entity; (d) your content, at the time you send it to Computachem Services, contains no virus or other code or material embedded in it which will have a negative impact on Computachem Services's services or infrastructure; (e) your content, your provision of your content to Computachem Services and the use by Computachem Services of your content, in each case as contemplated in these terms and conditions, does not breach any law (including laws relating to privacy, intellectual property and defamation) or the rights of any person; (f) you did not forge any TCP/IP packet header or any part of the header information in any email or SMS. (g) your content is not being provided for a commercial purpose (including that you are not soliciting funds or promoting particular goods or services); and
  9. Computachem Services shall have no liability to in connection with any loss or damage (including consequential loss or damage, or loss of revenue, profits or opportunity) which may be suffered or incurred or which may arise directly or indirectly in relation to your supply of your content to Computachem Services, or the subsequent use of your content by Computachem Services.
  10. On providing your content to Computachem Services for publication in any media, you indemnify Computachem Services and its officers, employees and agents against any damage or loss made against or suffered by any of those indemnified arising, in whole or in part, as a result of: (a) the publication by Computachem Services or a person permitted by Computachem Services of your content; or (b) a breach by you of these terms and conditions.
  11. When you provide us with your content Computachem Services will collect certain personal information about you. Details of the information we collect and its uses are set out in our Privacy Policy. Despite anything in that policy, however, we will not use your personal information collected in relation to you sending us your content to contact you with marketing offers, nor pass that information to our related companies for that purpose, however we may contact you for other reasons relating to your use of our site or the content you have submitted.
  12. These terms and conditions shall be governed by the laws of the state of New South Wales. The parties agree to submit to the exclusive jurisdiction of the courts exercising jurisdiction there.
  13. Nothing in these terms and conditions has any impact on the terms and conditions of use which apply to the relevant Computachem Services sites or other services.

 

health news headlines provided courtesy of Medical News Today.

Click here to read more...

If any difficulty is found in subscribing, please use the "Contact Us" panel found in the navigation bar with the message "subscribe" and your email address.

Subscribe to our mailing list

Email Format
 

 

  • Copyright (C) 2000-2017 Computachem Services, All Rights Reserved.

Website by Ablecode